{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:12:30Z","timestamp":1788343950149,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T00:00:00Z","timestamp":1527120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1130013"],"award-info":[{"award-number":["APP1130013"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1108043"],"award-info":[{"award-number":["APP1108043"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000927","name":"Prostate Cancer Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000927","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4473-8","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T08:08:04Z","timestamp":1527149284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Using high throughput microtissue culture to study the difference in prostate cancer cell behavior and drug response in 2D and 3D co-cultures"],"prefix":"10.1186","volume":"18","author":[{"given":"Eman","family":"Mosaad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Futrega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Robert","family":"Doran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,24]]},"reference":[{"issue":"4","key":"4473_CR1","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1172\/JCI43414","volume":"121","author":"Y Shiozawa","year":"2011","unstructured":"Shiozawa Y, Pedersen EA, Havens AM, Jung Y, Mishra A, Joseph J, Kim JK, Patel LR, Ying C, Ziegler AM, Pienta MJ, Song J, Wang J, Loberg RD, Krebsbach PH, Pienta KJ, Taichman RS. Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. J Clin Invest. 2011;121(4):1298\u2013312.","journal-title":"J Clin Invest"},{"issue":"5","key":"4473_CR2","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1053\/hp.2000.6698","volume":"31","author":"L Bubendorf","year":"2000","unstructured":"Bubendorf L, Sch\u00f6pfer A, Wagner U, Sauter G, Moch H, Willi N, Gasser TC, Mihatsch MJ. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000;31(5):578\u201383.","journal-title":"Hum Pathol"},{"issue":"4","key":"4473_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0090-4295(83)90147-4","volume":"21","author":"SC Jacobs","year":"1983","unstructured":"Jacobs SC. Spread of prostatic cancer to bone. Urology. 1983;21(4):337\u201344.","journal-title":"Urology"},{"key":"4473_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2003-12-4452","volume":"104","author":"Y Sakaguchi","year":"2004","unstructured":"Sakaguchi Y, Sekiya I, Yagishita K, Ichinose S, Shinomiya K, Muneta T. Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates. Blood. 2004;104:9.","journal-title":"Blood"},{"issue":"3","key":"4473_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1634\/stemcells.19-3-180","volume":"19","author":"P Bianco","year":"2001","unstructured":"Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells. 2001;19(3):180\u201392.","journal-title":"Stem Cells"},{"key":"4473_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1182\/blood-2012-08-451864","volume":"121","author":"M Corselli","year":"2013","unstructured":"Corselli M, Chin CJ, Parekh C, Sahaghian A, Wang W, Ge S, Evseenko D, Wang X, Montelatici E, Lazzari L, Crooks GM, P\u00e9ault B. Perivascular support of human hematopoietic stem\/progenitor cells. Blood. 2013;121:15.","journal-title":"Blood"},{"key":"4473_CR7","first-page":"2016","volume":"1092","author":"SA Bliss","year":"2016","unstructured":"Bliss SA, Sinha G, Sandiford O, Williams L, Engelberth DJ, Guiro K, Isenalumhe LL, Greco SJ, Ayer S, Bryan M, Kumar R, Ponzio N, Rameshwar P. Mesenchymal stem cell-derived exosomes stimulates cycling quiescence and early breast cancer dormancy in bone marrow. Cancer Res. 2016;1092:2016.","journal-title":"Cancer Res"},{"issue":"3","key":"4473_CR8","first-page":"181","volume":"6","author":"S Sieh","year":"2010","unstructured":"Sieh S, Lubik AA, Clements JA, Nelson CC, Hutmacher DW. Interactions between human osteoblasts and prostate cancer cells in a novel 3D in vitro model. Organ. 2010;6(3):181.","journal-title":"Organ"},{"issue":"7","key":"4473_CR9","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1046\/j.1464-410X.2003.04218.x","volume":"91","author":"Y Tokuda","year":"2003","unstructured":"Tokuda Y, Satoh Y, Fujiyama C, Toda S, Sugihara H, Masaki Z. Prostate cancer cell growth is modulated by adipocyte-cancer cell interaction. BJU Int. 2003;91(7):716\u201320.","journal-title":"BJU Int"},{"issue":"2","key":"4473_CR10","doi-asserted-by":"publisher","first-page":"e9093","DOI":"10.1371\/journal.pone.0009093","volume":"5","author":"APDN de Barros","year":"2010","unstructured":"de Barros APDN, Takiya CM, Garzoni LR, Leal-Ferreira ML, Dutra HS, Chiarini LB, Meirelles MN, Borojevic R, Rossi MID. Osteoblasts and bone marrow mesenchymal stromal cells control hematopoietic stem cell migration and proliferation in 3D in vitro model. PLoS One. 2010;5(2):e9093.","journal-title":"PLoS One"},{"issue":"11","key":"4473_CR11","doi-asserted-by":"publisher","first-page":"e111029","DOI":"10.1371\/journal.pone.0111029","volume":"9","author":"KF Chambers","year":"2014","unstructured":"Chambers KF, Mosaad EMO, Russell PJ, Clements JA, Doran MR. 3D cultures of prostate cancer cells cultured in a novel high-throughput culture platform are more resistant to chemotherapeutics compared to cells cultured in monolayer. PLoS One. 2014;9(11):e111029.","journal-title":"PLoS One"},{"issue":"7","key":"4473_CR12","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.biotechadv.2014.07.009","volume":"32","author":"X Xu","year":"2014","unstructured":"Xu X, Farach-Carson MC, Jia X. Three-dimensional in vitro tumor models for cancer research and drug evaluation. Biotechnol Adv. 2014;32(7):1256\u201368.","journal-title":"Biotechnol Adv"},{"issue":"3","key":"4473_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/mc.21844","volume":"52","author":"LC Kimlin","year":"2013","unstructured":"Kimlin LC, Casagrande G, Virador VM. In vitro three-dimensional (3D) models in cancer research: an update. Mol Carcinog. 2013;52(3):167\u201382.","journal-title":"Mol Carcinog"},{"key":"4473_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.addr.2014.03.001","volume":"69","author":"CR Thoma","year":"2014","unstructured":"Thoma CR, Zimmermann M, Agarkova I, Kelm JM, Krek W. 3D cell culture systems modeling tumor growth determinants in cancer target discovery. Adv Drug Deliv Rev. 2014;69:29\u201341.","journal-title":"Adv Drug Deliv Rev"},{"key":"4473_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.05.013","volume":"62","author":"K Futrega","year":"2015","unstructured":"Futrega K, Palmer JS, Kinney M, Lott WB, Ungrin MD, Zandstra PW, Doran MR. The microwell-mesh: a novel device and protocol for the high throughput manufacturing of cartilage microtissues. Biomaterials. 2015;62:1\u201312.","journal-title":"Biomaterials"},{"issue":"1","key":"4473_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41598-017-18050-1","volume":"8","author":"EO Mosaad","year":"2018","unstructured":"Mosaad EO, Chambers KF, Futrega K, Clements JA, Doran MR. The microwell-mesh: a high-throughput 3D prostate cancer spheroid and drug-testing platform. Sci Rep. 2018;8(1):253.","journal-title":"Sci Rep"},{"issue":"4","key":"4473_CR17","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nm.2112","volume":"16","author":"DW McMillin","year":"2010","unstructured":"McMillin DW, Delmore J, Weisberg E, Negri JM, Geer DC, Klippel S, Mitsiades N, Schlossman RL, Munshi NC, Kung AL, Griffin JD, Richardson PG, Anderson KC, Mitsiades CS. Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity. Nat Med. 2010;16(4):483\u20139.","journal-title":"Nat Med"},{"issue":"10","key":"4473_CR18","first-page":"2577","volume":"54","author":"N Thaimann","year":"1994","unstructured":"Thaimann N, Edmund E, Hopwood VL, Pathak S, Von Eschenbach A, Chung LWK, Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL, Pathak S, von Eschenbach AC, Chung LWK. Androgen-independent Cancer progression and bone metastasis in the LNCaP model of human prostate Cancer. Cancer Res. 1994;54(10):2577\u201382.","journal-title":"Cancer Res"},{"issue":"1","key":"4473_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3727\/096368909X478560","volume":"19","author":"BD Markway","year":"2010","unstructured":"Markway BD, Tan G-K, Brooke G, Hudson JE, Cooper-White JJ, Doran MR. Enhanced chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells in low oxygen environment micropellet cultures. Cell Transplant. 2010;19(1):29\u201342.","journal-title":"Cell Transplant"},{"issue":"4","key":"4473_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315\u20137.","journal-title":"Cytotherapy"},{"issue":"2","key":"4473_CR21","doi-asserted-by":"publisher","first-page":"e1565","DOI":"10.1371\/journal.pone.0001565","volume":"3","author":"MD Ungrin","year":"2008","unstructured":"Ungrin MD, Joshi C, Nica A, Bauwens C, Zandstra PW. Reproducible, ultra high-throughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates. PLoS One. 2008;3(2):e1565.","journal-title":"PLoS One"},{"issue":"7604","key":"4473_CR22","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature17954","volume":"533","author":"Z Li","year":"2016","unstructured":"Li Z, Alyamani M, Li J, Rogacki K, Abazeed M, Upadhyay SK, Balk SP, Taplin M-E, Auchus RJ, Sharifi N. Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy. Nature. 2016;533(7604):547\u201351.","journal-title":"Nature"},{"key":"4473_CR23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.critrevonc.2015.08.023","volume":"97","author":"S Arcangeli","year":"2016","unstructured":"Arcangeli S, Zilli T, De Bari B, Alongi F. Hit the primary\u2019: a paradigm shift in the treatment of metastatic prostate cancer? Crit Rev Oncol Hematol. 2016;97:231\u20137.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"4473_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jbo.2016.02.005","volume":"5","author":"AM Decker","year":"2016","unstructured":"Decker AM, Jung Y, Cackowski F, Taichman RS. The role of hematopoietic stem cell niche in prostate cancer bone metastasis. J Bone Oncol. 2016;5(3):117\u201320.","journal-title":"J Bone Oncol"},{"key":"4473_CR25","first-page":"175","volume-title":"New concepts on the critical functions of Cancer- and metastasis-initiating cells in treatment resistance and disease relapse: molecular mechanisms, signaling transduction elements and novel targeting therapies","author":"M Mimeault","year":"2010","unstructured":"Mimeault M, Batra SK. New concepts on the critical functions of Cancer- and metastasis-initiating cells in treatment resistance and disease relapse: molecular mechanisms, signaling transduction elements and novel targeting therapies. Dordrecht: Springer; 2010. p. 175\u2013207."},{"issue":"11","key":"4473_CR26","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s00109-015-1329-4","volume":"93","author":"G Ren","year":"2015","unstructured":"Ren G, Esposito M, Kang Y. Bone metastasis and the metastatic niche. J Mol Med. 2015;93(11):1203\u201312.","journal-title":"J Mol Med"},{"issue":"5","key":"4473_CR27","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/sj.clpt.6100296","volume":"83","author":"M Mimeault","year":"2008","unstructured":"Mimeault M, Hauke R, Batra S. Recent advances on the molecular mechanisms involved in the drug resistance of Cancer cells and novel targeting therapies. Clin Pharmacol Ther. 2008;83(5):673\u201391.","journal-title":"Clin Pharmacol Ther"},{"key":"4473_CR28","first-page":"11","volume":"62","author":"JA Tuxhorn","year":"2002","unstructured":"Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE, Rowley DR. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Res. 2002;62:11.","journal-title":"Cancer Res"},{"issue":"5","key":"4473_CR29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1530\/ERC-13-0151","volume":"20","author":"WN Brennen","year":"2013","unstructured":"Brennen WN, Denmeade SR, Isaacs JT. Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment. Endocr Relat Cancer. 2013;20(5):269\u201390.","journal-title":"Endocr Relat Cancer"},{"issue":"21","key":"4473_CR30","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1038\/onc.2013.233","volume":"33","author":"J Luo","year":"2014","unstructured":"Luo J, Ok Lee S, Liang L, Huang C-K, Li L, Wen S, Chang C. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling. Oncogene. 2014;33(21):2768\u201378.","journal-title":"Oncogene"},{"issue":"10","key":"4473_CR31","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1002\/stem.1191","volume":"30","author":"JH Yl\u00d6stalo","year":"2012","unstructured":"Yl\u00d6stalo JH, Bartosh TJ, Coble K, Prockop DJ. Human mesenchymal stem\/stromal cells cultured as spheroids are self-activated to produce prostaglandin E2 that directs stimulated macrophages into an anti-inflammatory phenotype. Stem Cells. 2012;30(10):2283\u201396.","journal-title":"Stem Cells"},{"key":"4473_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1084\/jem.20122252","volume":"210","author":"S Pinho","year":"2013","unstructured":"Pinho S, Lacombe J, Hanoun M, Mizoguchi T, Bruns I, Kunisaki Y, Frenette PS. PDGFR\u03b1 and CD51 mark human nestin+ sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion. J Exp Med. 2013;210:7.","journal-title":"J Exp Med"},{"issue":"1","key":"4473_CR33","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","volume":"159","author":"D Gao","year":"2014","unstructured":"Gao D, Vela I, Sboner A, Iaquinta PJ, Karthaus WR, Gopalan A, Dowling C, Wanjala JN, Undvall EA, Arora VK, Wongvipat J, Kossai M, Ramazanoglu S, Barboza LP, Di W, Cao Z, Zhang QF, Sirota I, Ran L, MacDonald TY, Beltran H, Mosquera J-M, Touijer KA, Scardino PT, Laudone VP, Curtis KR, Rathkopf DE, Morris MJ, Danila DC, Slovin SF, Solomon SB, Eastham JA, Chi P, Carver B, Rubin MA, Scher HI, Clevers H, Sawyers CL, Chen Y. Organoid cultures derived from patients with advanced prostate Cancer. Cell. 2014;159(1):176\u201387.","journal-title":"Cell"},{"issue":"1","key":"4473_CR34","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12967-014-0278-y","volume":"12","author":"N Yang","year":"2014","unstructured":"Yang N, Yan T, Zhu H, Liang X, Leiss L, Sakariassen P, Skaftnesmo K, Huang B, Costea D, Enger P, Li X, Wang J. A co-culture model with brain tumor-specific bioluminescence demonstrates astrocytes-induced drug resistance in glioblastoma. J Transl Med. 2014;12(1):278.","journal-title":"J Transl Med"},{"issue":"7408","key":"4473_CR35","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nature11183","volume":"487","author":"R Straussman","year":"2012","unstructured":"Straussman R, Morikawa T, Shee K, Barzily-Rokni M, Qian ZR, Du J, Davis A, Mongare MM, Gould J, Frederick DT, Cooper ZA, Chapman PB, Solit DB, Ribas A, Lo RS, Flaherty KT, Ogino S, Wargo JA, Golub TR. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature. 2012;487(7408):500\u20134.","journal-title":"Nature"},{"issue":"5","key":"4473_CR36","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00285-003-0238-2","volume":"48","author":"D Ambrosi","year":"2004","unstructured":"Ambrosi D, Mollica F. The role of stress in the growth of a multicell spheroid. J Math Biol. 2004;48(5):477\u201399.","journal-title":"J Math Biol"},{"issue":"13","key":"4473_CR37","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.addr.2007.08.006","volume":"59","author":"S Rhee","year":"2007","unstructured":"Rhee S, Grinnell F. Fibroblast mechanics in 3D collagen matrices. Adv Drug Deliv Rev. 2007;59(13):1299\u2013305.","journal-title":"Adv Drug Deliv Rev"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4473-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4473-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4473-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T19:12:25Z","timestamp":1558638745000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4473-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,24]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4473"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4473-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,24]]},"assertion":[{"value":"28 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None of the prostate cancer cell lines used in this study required institutional human ethics approval. Only the collection of bone marrow aspirate donations required human ethics approval. Ethical approval was granted through the Mater Health Services Human Research Ethics Committee and Queensland University of Technology Ethics Committee (number: 1000000938), in accordance with the Australian National Health and Medical Research Council\u2019s Statement on Ethical Conduct in Research Involving Humans. Volunteer bone marrow donors were informed, and provided written consent prior to participating.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"592"}}